ALX Oncology Holdings Inc. Profile Avatar - Palmy Investing

ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatm…

Biotechnology
US, South San Francisco [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ALXO's Analysis
CIK: 1810182 CUSIP: 00166B105 ISIN: US00166B1052 LEI: - UEI: -
Secondary Listings
ALXO has no secondary listings inside our databases.